Aldose reductase
Hamada, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 11): 448-451
2004
ISSN/ISBN: 0047-1852 PMID: 15628442 Document Number: 568963
Document emailed within 1 workday
Related Documents
Nakamura, J.; Itoh, S.; Kani, K.; Okamoto, R. 1998: Metabolic changes of aldose and phosphorus metabolites in incubated rabbit lenses--effects of aldose reductase inhibitor Nippon Ganka Gakkai Zasshi 102(9): 561-569Ansari, N.H.; Bhatnagar, A.; Liu, S.Q.; Srivastava, S.K. 1991: Purification and characterization of aldose reductase and aldehyde reductase from human kidney Biochemistry International 25(4): 755-765
Erkelens, D.W.; Bravenboer, B. 1990: Aldose reductase inhibitors in diabetic neuropathy Nederlands Tijdschrift Voor Geneeskunde 134(15): 775-776
Nakayama, T.; Tanimoto, T.; Kador, P.F. 1989: Human erythrocyte aldose and aldehyde reductase Progress in Clinical and Biological Research 290: 265-277
Nishimura, C.; Hamada, Y.; Tachikawa, T.; Ishikawa, T.; Gui, T.; Tsubouchi, J.; Hotta, N.; Tanimoto, T.; Urakami, T. 1994: Enzyme immunoassay for erythrocyte aldose reductase Clinical Chemistry 40(6): 889-894
Parmar, N.S.; Ghosh, M.N. 1981: Lens aldose reductase in diabetic and galactosemic cataracts Indian Journal of Physiology and Pharmacology 25(3): 193-200
Kador, P.F.; Sharpless, N.E. 1983: Pharmacophor requirements of the aldose reductase inhibitor site Molecular Pharmacology 24(3): 521-531
Gervasi, G.B.; Bartoli, C.; Catalani, R.; Farina, C.; Carpita, G.; Caccia, G.; Ammannati, P. 1991: Effects of a new aldose reductase inhibitor on diabetic complications in rats Arzneimittel-Forschung 41(11): 1160-1163
Van den Hoven, W.E.; Hall, D.W.; Burns, J.W. 1984: Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate British Journal of Clinical Practice. Suppl 34: 31-33
Varma, S.D. 1986: Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications Progress in Clinical and Biological Research 213: 343-358
Haraguchi, H.; Ohmi, I.; Masuda, H.; Tamura, Y.; Mizutani, K.; Tanaka, O.; Chou, W.H. 1996: Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes Experientia 52(6): 564-567
Wright, M.; Hill, S.; Slaney, M.A. 1994: The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy Medical Journal of Australia 160(1): 45
Yue, D.K.; Brooks, B. 1993: The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy Medical Journal of Australia 159(2): 76-78
Terranova, R.; Luca, S. 1993: Treatment with an aldose reductase inhibitor in peripheral neuropathy in elderly diabetic patients Minerva Medica 84(9): 461-466
Dent, M.T.; Tebbs, S.E.; Gonzalez, A.M.; Ward, J.D.; Wilson, R.M. 1991: Neutrophil aldose reductase activity and its association with established diabetic microvascular complications Diabetic medicine: a journal of the British Diabetic Association 8(5): 439-442
Primofiore, G.; Da Settimo, F.; La Motta, C.; Simorini, F.; Minutolo, A.; Boldrini, E. 1997: Benzisothiazole-1,1-dioxide alkanoic acid derivatives as inhibitors of rat lens aldose reductase Farmaco 52(10): 583-588
Kuchmerovskaia, T.M.; Donchenko, G.V.; Klimenko, A.P.; Chichkovskaia, G.V.; Pakirbaeva, L.V.; Kozitskiĭ, Z.I.; Efimov, A.S. 1997: Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes Ukrainskii Biokhimicheskii Zhurnal 69(3): 77-82
Kador, P.F.; Akagi, Y.; Kinoshita, J.H. 1985: Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors Diabetic Medicine: a Journal of the British Diabetic Association 2(3): 194-196
Maragoudakis, M.E.; Wasvary, J.; Hankin, H.; Gargiulo, P. 1984: Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin Molecular Pharmacology 25(3): 425-430
Kiss, A.D.; Haggard, K.; Veltman, J.C.; Ziegler, D.M. 1992: Oxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 948-953